Status:
UNKNOWN
Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
Lead Sponsor:
Imperial College Healthcare NHS Trust
Conditions:
Strongyloidiasis
Bone Marrow Transplant Infection
Eligibility:
All Genders
18+ years
Brief Summary
Strongyloidiasis is a worm infection which affects more than 100 million people, mostly in Africa, Asia and Latin America, and can cause severe illness in people with reduced immunity. In the UK, the ...
Detailed Description
Strongyloidiasis is a worm infection which affects more than 100 million people, mostly in Africa, Asia and Latin America. Infection can persist for decades, and usually causes mild symptoms. In some ...
Eligibility Criteria
Inclusion
- Adult patients
- Under care of Haematology at ICHNT
- Undergoing BMT Jun 2018 - July 2020 ('pre-screening group') or July 2020 - July 2021 ('screened group')
Exclusion
- Age \< 18 years (i.e. managed as paediatric BMT)
- Previous BMT but no Strongyloides serology result available at the time of data collection
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04709848
Start Date
February 1 2021
End Date
December 1 2021
Last Update
January 14 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.